Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1NET 1Gynecologic 1Endocrine 1Breast 1

Conditions

Neuroendocrine Tumors 14Thyroid Neoplasms 1Thymoma 1Teratoma 1Sarcoma 1Parkinson Disease 1Neoplasms 1Mesothelioma 1Lung Neoplasms 1Hypersensitivity 1Gastro-enteropancreatic neuroendocrine tumor 1Disease 1Carcinoma, Lobular 1Carcinoma, Hepatocellular 1Adenoma, Islet Cell 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Hypersensitivity × NET × Clear all
NCT01673906 2025-06-24

68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours

Azienda USL Reggio Emilia - IRCCS

Phase 2 Completed
142 enrolled
EndocrineNET

Hypersensitivity, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡